Chinese Medicine Group, Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association. Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 783-788. DOI: 10.12290/xhyxzz.2022-0428
Citation: Chinese Medicine Group, Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association. Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 783-788. DOI: 10.12290/xhyxzz.2022-0428

Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era

More Information
  • Corresponding author: HU Jingqing, E-mail: gcp306@126.com

  • Received Date: August 04, 2022
  • Accepted Date: August 16, 2022
  • Available Online: September 14, 2022
  • Issue Publish Date: September 29, 2022
  • To address the challenges of the new era and promote the rational application of clinical epidemiology and evidence-based medicine methods in traditional Chinese medicine (TCM), Chinese Medicine Group, the Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association, gathered the related experts from all over the country and developed a consensus to improve the application of clinical epidemiology and evidence-based medicine methods in TCM. Delphi survey, consensus meetings and nominal groups were adopted in the process. This consensus summarizes the major challenges in the research of TCM and provides theoretical guidance for the development and application of clinical epidemiology and evidence-based medicine in TCM.
  • [1]
    符宇, 邵明义, 赵瑞霞, 等. 基于中医证据的中医临床疗效评价方法探讨[J]. 中医杂志, 2020, 61: 1124-1129. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202013005.htm
    [2]
    陈可冀, 钱振淮, 张问渠, 等. 精制冠心片双盲法治疗冠心病心绞痛112例疗效分析[J]. 中华心血管病杂志, 1982, 10: 85-89. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ198211015.htm
    [3]
    李幼平, 刘鸣. 循证医学与中医药现代化[J]. 中国中医药信息杂志, 1999, 6: 14-16, 32. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY199912008.htm
    [4]
    Zhang YQ, Jiao RM, Witt CM. How to design high quality acupuncture trials-a consensus informed by evidence[J]. BMJ, 2022, 376: e067476.
    [5]
    衣琳. 探究"天人合一"思想对中医学影响[J]. 中西医结合心血管病电子杂志, 2019, 7: 21, 23. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXJH201914013.htm
    [6]
    Thomas SK. The Structure of Scientific Revolutions[M]. Chicago: University of Chicago Press, 1996: 1-212.
    [7]
    张新江, 张新雪, 赵宗江. 中西医结合研究范式的思考与探索[J]. 世界科学技术-中医药现代化, 2021, 23: 3859-3865. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202111004.htm
    [8]
    Rapport F, Braithwaite J. Are we on the cusp of a fourth research paradigm?Predicting the future for a new approach to methods-use in medical and health services research[J]. BMC Med Res Methodol, 2018, 18: 131. DOI: 10.1186/s12874-018-0597-4
    [9]
    Guyatt GH, Oxman AD, Schvnemann HJ. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology[J]. J Clin Epidemiol, 2011, 64: 380-382. DOI: 10.1016/j.jclinepi.2010.09.011
    [10]
    吴大嵘. 浅谈中医多来源证据特点及其评析方法[C]. 第八届中医/中西医结合循证医学方法研讨会会议材料, 2014: 42-43.
    [11]
    陈薇, 方赛男, 刘建平. 基于证据体的中医药临床证据分级标准建议[J]. 中国中西医结合杂志, 2019, 39: 358-364. DOI: 10.7661/j.cjim.20190123.062
    [12]
    牟玮, 翟静波, 李杰, 等. 中医临床证据的转化策略—决策辅助工具的研制[J]. 世界中医药, 2017, 12: 1261-1267. DOI: 10.3969/j.issn.1673-7202.2017.06.012
    [13]
    刘保延, 王永炎. 证候、证、症的概念及其关系的研究[J]. 中医杂志, 2007, 48: 293-296, 298. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200704000.htm
    [14]
    宋美芳, 陈家旭, 彭晨习, 等. 论中医微观辨证[J]. 中华中医药杂志, 2019, 34: 2867-2869. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201907007.htm
    [15]
    春柳, 谢洋, 赵虎雷, 等. 基于文献的中医证候诊断规范研制现状分析[J]. 中医杂志, 2021, 62: 169-172. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202102017.htm
    [16]
    陶嘉磊, 袁斌, 汪受传. 中医证候学研究的技术方法及其运用现状[J]. 中华中医药杂志, 2018, 33: 2982-2985. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201807076.htm
    [17]
    于东林, 胡镜清. 关于中医证候诊断标准研究的思考[J]. 中华中医药杂志, 2021, 36: 4110-4113. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107085.htm
    [18]
    吴朦. 中医复杂干预临床研究报告规范研究[D]. 北京: 中国中医科学院, 2014.
    [19]
    吴朦. 中风病气虚血瘀证中医复杂干预研究与综合评价[D]. 北京: 中国中医科学院, 2017.
    [20]
    董斐, 刘建平. 从"经验"到"证据": 循证医学促进中医药传承创新发展[J]. 南京中医药大学学报, 2021, 37: 642-647. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202105002.htm
    [21]
    Sedgwick P. Understanding the ecological fallacy[J]. BMJ, 2015, 351: h4773.
    [22]
    Huang K, Zhang P, Zhang Z. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms[J]. Pharmacol Ther, 2021, 225: 107843.
    [23]
    梁宁, 陈雅馨, 李慧珍, 等. 新型冠状病毒肺炎疫情下快速动态化制订循证中医指南的思考[J]. 中国中西医结合杂志, 2022, 42: 218-222. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202202014.htm
    [24]
    Ziemssen T, Medin J, Couto CAM. Multiple sclerosis in the real world: A systematic review of fingolimod as a case study[J]. Autoimmun Rev, 2017, 16: 355-376.
    [25]
    Izquierdo G, Damas F, Pápamo MD. The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study[J]. PloS One, 2017, 12: e0176174.
    [26]
    Ziemssen T, Lang M, Tackenberg B. Real-world persistence and benefit-risk. profile of fingolimod over 36 months in Germany[J]. Neurol Neuroimmunol Neuroinflamm, 2019, 6: e548.
    [27]
    贾玉龙, 姚明宏, 刘艳梅, 等. 特许医疗政策下真实世界数据治理的模式探索[J]. 中国循证医学杂志, 2021, 21: 1373-1380. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202112001.htm
    [28]
    柏柳安宁, 夏结来, 王陵, 等. 真实世界研究中的常见偏倚及其控制[J]. 中国临床药理学与治疗学, 2020, 25: 1422-1428. https://www.cnki.com.cn/Article/CJFDTOTAL-YLZL202012016.htm
    [29]
    刘保延. 真实世界的中医临床科研范式[J]. 中医杂志, 2013, 54: 451-455. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201306003.htm
    [30]
    张润顺, 王映辉, 刘保延, 等. 基于共享系统的真实世界中医临床研究范式初步实施方案的设计[J]. 中医杂志, 2014, 55: 1551-1554. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201418008.htm
    [31]
    李昱佳, 陈垂雄, 黄丽红, 等. 不同领域现实世界临床研究证据转化的应用策略[J]. 中国临床医学, 2021, 28: 744-750. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202105005.htm
    [32]
    Li M, Chen S, Lai Y. Integrating Real-World Evidence in. the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model[J]. Front Med (Lausanne), 2021, 8: 669509.
  • Related Articles

    [1]Professional Panel on Injection Aesthetics, National Quality Control Center for Plastic and Aesthetic Surgery. Consensus of Chinese Experts on Neck Injection Aesthetics (2024 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1289-1300. DOI: 10.12290/xhyxzz.2024-0617
    [2]ZHU Di, LUO Xufei, WANG Zijun, SHI Qianling, LI Haodong, WANG Ye, CHEN Yaolong. The Differences and Connections Among Expert Evidence, Expert Opinion and Expert Consensus in the Development of Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 936-941. DOI: 10.12290/xhyxzz.2024-0542
    [3]LIANG Changhao, YIN Guanxiang, WANG Yaqi, LIU Siqi, GAO Yicheng, LIU Pengwei, SU Xiangfei, FEI Yutong. Application of Delphi Method in the Development and Revision of Clinical Practice Guidelines of Traditional Chinese Medicine: Process and Suggestions[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1084-1090. DOI: 10.12290/xhyxzz.2022-0649
    [4]National Center for Quality Assurance of Anesthesia. 2023 Chinese Expert Consensus Statement for Prevention and Management of Perioperative Hypothermia[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 734-743. DOI: 10.12290/xhyxzz.2023-0266
    [5]Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
    [6]Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital National Rare Diseases Committee. Expert Consensus on Clobazam in the Treatment of Refractory Epilepsy (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 768-782. DOI: 10.12290/xhyxzz.2022-0421
    [7]Chinese Society of Nuclear Medicine, Chinese Society of Molecular Imaging in Chinese Biophysical Society. Expert Consensus on Clinical Application of Integrin RGD Receptor Imaging (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 227-234. DOI: 10.12290/xhyxzz.2022-0089
    [8]YU Jiren, WANG E, WANG Difen, CANG Jing, FENG Yi, ZHANG Xijing, YANG Yi, YANG Yunmei, WU Shuijing, WANG Weijian, DU Bin, SHANG You, LIN Ru, CHENG Baoli, XIE Guohao, FANG Xiangming. Expert Consensus on Perioperative Management of Elderly Septic Patients (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 481-489. DOI: 10.12290/xhyxzz.2021-0312
    [9]Chinese Committee on Antimicrobial Susceptibility Testing, European Committee on Antimicrobial Susceptibility Testing, European Society of Clinical Microbiology and Infectious Diseases, Expert Committee on Infectious Diseases, China Medical Education Association, YANG Qi-wen, MA Xiao-ling, HU Fu-pin, ZHANG Jing, SUN Tong-wen, CHEN Bai-yi, XU Ying-chun, LIU You-ning. Expert Consensus on Polymyxin Antimicrobial Susceptibility Testing and Clinical Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 559-570. DOI: 10.3969/j.issn.1674-9081.2020.05.011
    [10]Yao-long CHEN, Xu-fei LUO, Ji-yao WANG, Xiao-qing LIU, Hong-cai SHANG, Ke-hu YANG. How to Distinguish between Clinical Practice Guidelines and Expert Consensus[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 403-408. DOI: 10.3969/j.issn.1674-9081.2019.04.018
  • Cited by

    Periodical cited type(11)

    1. 卢存存,陈子佳,王志飞. 基于真实世界数据的观察性因果推断研究新框架(目标试验模拟)及其在中医药领域中的应用展望. 协和医学杂志. 2024(02): 422-428 . 本站查看
    2. 中西医联合防治策略标准研究项目组. 《中西医联合防治优势病种临床应用指南》制定技术规范. 中国中西医结合杂志. 2024(04): 389-398 .
    3. 张佳乐,吴珊,杨燕,陈南杰,汪锦城,胡镜清. 火热证诊断条目筛选与构建. 世界科学技术-中医药现代化. 2024(02): 511-516 .
    4. 赵军宁,黄璐琦. 中药监管科学:发展中的新兴融合科学. 中国科学基金. 2024(03): 396-405 .
    5. 张浩然,张成,李双婧,闫世艳. 中医药病例注册登记研究数据统计分析方法的应用现况. 世界科学技术-中医药现代化. 2024(08): 2047-2054 .
    6. 赵军宁. 中药监管科学:助力更高水平的中药科学监管. 中国药学杂志. 2023(09): 749-761 .
    7. 黄秀珍,戴森戈,蔡夏琴. 我院妇产科病区2019—2021年中药处方特征分析及药学管理工作定位. 中医药管理杂志. 2023(09): 98-100 .
    8. 张成,王玉光,闫世艳. 主方案伞式设计在中医药临床研究中的应用. 北京中医药. 2023(05): 487-490 .
    9. 崔萌萌,李风森,徐丹. 玉屏风制剂治疗慢性阻塞性肺疾病随机对照试验的质量评价. 新疆医科大学学报. 2023(08): 1084-1091 .
    10. 刘少南,郭新峰,吴大嵘,Anthony Lin Zhang,Charlie Changli Xue,温泽淮. 基于循证医学原则的中医干预类临床证据分级系统的构建. 中国中西医结合杂志. 2023(08): 911-915 .
    11. 黄晓强,朴胜华,荣向路,朱青,詹会霞,金英花,郭姣. 2型糖尿病湿热证五种权重研究方法的诊断性试验准确性比较研究. 中医杂志. 2023(19): 1981-1987 .

    Other cited types(3)

Catalog

    Article Metrics

    Article views (4765) PDF downloads (233) Cited by(14)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close